Expanded Access: Bridging the Gap to Support Patients Beyond Clinical Trials
Expanded Access, also known as Post-Trial Access or Compassionate Use, can be a vital pathway for patients seeking continued access to investigational medicine after a clinical trial ends—or for those unable to participate in a trial in the first place.
For drug companies, however, Expanded Access requires more than good intentions. It demands strategic planning, operational coordination, and a clear understanding of how to build a program that is both compliant and sustainable.
Join this webcast for a practical overview of Expanded Access: what it is, why it matters, and how to set your organization up for success. Attendees will leave with actionable insights on key considerations, common pitfalls, and how to get started.
Please be advised that photographs and videos will be taken during this event. By registering and attending, you consent to BDO using these images for promotional purposes, including on our website and in marketing materials. You may view the full photography and videography terms and conditions here.